M. R. Charlton, E. J. Gane, M. P. Manns et al., “Sofosbuvir and ribavirin for the treatment of established recurrent hepatitis C infection after liver transplantation: preliminary results of a prospective, multicenter study,” in Program and Abstracts of the 64th Annual Meeting of the American Association for the Study of Liver Diseases, Abstract LB-2, Washington, DC, USA, November 2013.

R. Satokar, J. Ahn, H. Te et al., “Sofosbuvir as the backbone of treatment for HCV after liver transplantation: a real-life multicenter experience,” in Proceedings of the 65th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting, pp. 532A–545A, Boston, Mass, USA, October 2014.

K. Deterding, C. Höner zu Siederdissen, K. Port et al., “Delayed early HCV RNA response during IFN-free therapy with sofosbuvir in interferon-ineligible patients with advanced cirrhosis,” in Proceedings of the 65th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting, pp. 659A–709A, Boston, Mass, USA, October 2014.

P. Gaglio, C. E. Glick, and J. Reinus, “Survey on pre- and post-transplant management of hepatitis C: response from medical directors of US transplant programs,” in Proceedings of the 65th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting, Hepatology, p. 544A, Boston, Mass, USA, October 2014.